Latest news
Recursion Pharmaceuticals (RXRX) Is Up 11.4% After Mixed Q2 Results And Genentech Milestone Update - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 15:13:31 GMTRecursion advances neuroscience drug target wit... - PluangPluang · Wed, 05 Aug 2026 11:27:44 GMTRecursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program - The Daily Tribune NewsThe Daily Tribune News · Wed, 05 Aug 2026 10:30:00 GMT